Download presentation
Presentation is loading. Please wait.
Published byChristina Hart Modified over 8 years ago
1
EVALUATING THE EFFECTIVENESS OF THE AGS UPDATED 2012 BEERS CRITERIA AS AN EDUCATIONAL TOOL IN A FAMILY MEDICINE RESIDENCY TRAINING PROGRAM Eseoghene Abokede MD Ngodup Tsewang MD Introduction Discussion Methods Results Conclusion Polypharmacy and prescription of Potentially Inappropriate Medications (PIMs) have been an ongoing problem in long-term care facilities (LTCF) Use of multiple medications is not always inappropriate, but polypharmacy and PIMs have been associated with increased risks including adverse drugs events (ADEs), and medication non- adherence 1 resulting in poor outcomes. Beers list contains a list of medications with side effects far more destructive than any potential therapeutic benefits in the elderly. This study evaluates and assesses the effectiveness of the updated 2012 AGS Beers criteria as a tool for educating clinicians with regards to drug utilization and prescription. Safety, side effect profile, drug interactions, patient and family goal of care and life expectancy should be considered when prescribing medications Didactic provided an experiential learning opportunity for proper medication management based on current evidence and standard of care One of the limitations of the study is the age range of patients, between 39-97. The Beers list is applicable to elderly >65 yrs. Although, this individuals did indeed have physiologic ailments that required LTCF Department of Family and Community Medicine, Hennepin County Medical Center, Minneapolis MN As part of didactic curricula, Resident Physicians where educated on AGS Beers Criteria and provided with pocket guides Each of 19 resident physicians had between 1-3 Nursing home residents assigned to them Resident Physicians reviewed their patients medications and identified any listed on the Beers list Rationale for continuation vs discontinuation vs gradual dose reduction were discussed A post survey was conducted to assess perception about the effectiveness of the AGS tool Awareness of Polypharmacy and PIMs can help reduce risks and adverse effects of drug interactions AGS Beers List is a useful tool in Physician education Age of NH patients (Mean/SD)65.3 ± 11.5 Sex (Male/Female) (%)64.6/35.4 Patients on >5 drugs (%)89.5 Avg. no of drugs per Pt13.2 ± 5.8 No. of Pt on PIMS (%)83.3* No. of Pt W/ changes for PIMs (%)15 Most common drug classesAntipsychotics, Benzodiazepines Most common diagnosis (by number of those affected) Schizophrenia (13), Dementia (5), Vascular disorders (31), Other psychiatric illnesses (20) Survey: Using the AGS Updated 2012 Beers Criteria as a tool for Medication Management No. of Resident Physicians involved in Study 19 No. of respondents with prior knowledge of Beers criteria as a management tool (%) 52.6 No. of respondents without prior knowledge of Beers criteria as a management tool (%) 47.4 Perceived usefulness of tool in LTCF patient management 5- Extremely Useful 9-Very useful 4- Mostly useful 1- Somewhat useful Perceived usefulness of tool in future practice 2- Extremely Useful 14- Very useful 0- Mostly useful 3- Somewhat useful References 1.Peron EP, Ogbonna K, Donohoe KL. Antidiabetic Medications and Polypharmacy. Clin Geriatr Med. 2015; 31: 17-27 2.Gurwitz JH, Field TS, Judge J et al. The Incidence of adverse drug events in two large academic long term care facilities. Am J Me. 205; 118:251-258. 3.Medical Expenditure Panel Survey. U.S Department of Health and Human Services Web site. http://meps.ahrq.gov/mepsweb/data_stats/summ_tables/hc/drugs/2012/hcdruges t_totexp2012.shtml. Accessed March 2, 2015. http://meps.ahrq.gov/mepsweb/data_stats/summ_tables/hc/drugs/2012/hcdruges t_totexp2012.shtml 4.Fick D, Semla T, Beizer J et al. The American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. JAGS. 2012; 60: 616-631. doi: 10.1111/j.1532-5415.2012.03923.x
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.